Aug 30, 2024 | Antithrombotics
2) Our returning esteemed guest faculty is C. Michael Gibson MD @CMichaelGibson, Non-Profit Founder/Leader &❤️ Doc from @harvardmed. #cmg will review the #ESC2024 presentations on #OCEANIC_AF (#asundexian) and periprocedural 🩸from #AZALEA #TIMI-71 (#abelacimab)....
Jun 3, 2024 | Antithrombotics
2) This is an @cardiomet_CE #JournalClub on "Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis," just pub'd in @PharmacoJournal; @CMichaelWhite2 was lead author. Follow this 🧵for 0.5hr...
May 23, 2024 | Antithrombotics
2) We spend alot of time discussing in these programs the management of the most feared 🩸 complication of #DOAC therapy–#ICH. We respect it! But we also must recognize that the most COMMON 🩸issue in this space is from the #gastrointestinal tract.—...
May 13, 2024 | Antithrombotics
2) Our first-time expert author is #ANNEXa_I investigator David Seiffge MD @DavidSeiffge, Vascular neurologist at Inselspital Bern 🇨🇭#FOAMed #FOAMcc #neurotwitter #cardiotwitter #ICH @ESOStroke @WorldStrokeOrg pic.twitter.com/RDJPwWn6fb— cardio-met...
Mar 17, 2024 | Antithrombotics
1b) @AnticoagPharmD is Systems Director of Anticoagulation Services and also is the Co-Chair of the @NATF Thrombosis Medical Advisory Board & the @AnticoagForum ACE committee. She will be discussing the very exciting #CodeICH project that launched with...
Feb 26, 2024 | Antithrombotics
2) The article is at 🔓https://t.co/pcn3xUfoWf and our content expert for this program is the 1⃣st author, Kevin Sheth MD @sheth_kevin, Professor of #Neurology & #Neurosurgery from @YaleMed & the Yale Center for Brain & Mind Health (CBMH) 🧠...